Mediterr J Rheumatol 2019;30(1):26-32
Certified Reference Materials and their need for the diagnosis of autoimmune diseases
Authors Information

European Commission, Joint Research Centre (JRC), Geel, Belgium

  1. Lerner A, Jeremias P, Matthias T. The World Incidence and Prevalence of Autoimmune Diseases is Increasing. International Journal of Celiac Disease 2015;3(4):151-5. [https://doi.org/10.12691/ijcd-3-4-8]
  2. The Cost Burden of Autoimmune Disease: The Latest Front in the War on Healthcare Spending [press release]. 22100 Gratiot Avenue, Eastpointe, MI 480212011.
  3. Shoenfeld Y, Cervera R, Gershwin E. Diagnostic Criteria in Autoimmune Diseases. Shoenfeld PY, Cervera PR, Gershwin ME, editors: Humana Press; 2008.
  4. Ramos-Casals M, Brito-Zerón P, Kostov B, Sisó-Almirall A, Bosch X, Buss D, et al. Google-driven search for big data in autoimmune geoepidemiology: Analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun Rev 2015;14(8):670-9. [https://doi.org/10.1016/j.autrev.2015.03.008] [PMID: 25842074]
  5. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126(6):1504-17. [PMID: 15168363]
  6. Whitton ME, Pinart M, Batchelor J, Leonardi‐Bee J, González U, Jiyad Z, et al. Interventions for vitiligo. Cochrane Database Syst Rev 2015;24(2): CD003263. [https://doi.org/10.1002/14651858.CD003263.pub5] [PMID: 25710794]
  7. Kappelman MD, Rifas–Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al. The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States. Clin Gastroenterol Hepatol 2007;5(12):1424-9. [https://doi.org/10.1016/j.cgh.2007.07.012] [PMID: 17904915]
  8. Bullard KM, Cowie CC, Lessem SE, Saydah SH, Menke A, Geiss LS, et al. Prevalence of Diagnosed Diabetes in Adults by Diabetes Type - United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67(12):359-61. [https://doi.org/10.15585/mmwr.mm6712a2]
  9. Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol Int 2017;37(9):1551-7. [https://doi.org/10.1007/s00296-017-3726-1] [PMID: 28455559]
  10. Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of Primary Sjögren's Syndrome in a US Population-Based Cohort. Arthritis Care Res 2017;69(10):1612-6. [https://doi.org/10.1002/acr.23173] [PMID: 27998024] [PMCID: PMC5478481]
  11. Berti A, Cornec D, Crowson C, Specks U, Matteson E. The Epidemiology of ANCA Associated Vasculitis in the U.S.: A 20 Year Population Based Study. Arthritis Rheumatol 2017;69(suppl 10). [https://acrabstracts.org/abstract/the-epidemiology-of-anca-associated-vasculitis-in-the-u-s-a-20-year-population-based-study/]
  12. Silverberg NB. The Epidemiology of Vitiligo. Curr Dermatol Rep 2015;4(1):36-43.
  13. Cooper GS, Bynum MLK, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009;33(3-4):197-207. [https://doi.org/10.1016/j.jaut.2009.09.008] [PMID: 19819109] [PMCID: PMC2783422]
  14. Michels A, Michels N. Addison disease: early detection and treatment principles. Am Fam Physician 2014;89(7):563-8. [PMID: 24695602]
  15. McAllister BP, Williams E, Clarke K. A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies. Clin Rev Allergy Immunol  2018 Jun 2. [https://doi.org/10.1007/s12016-018-8691-2] [PMID: 29858750]
  16. Mascolo M, McNeill A, Fernandes M. Study for the ENVI Committee: Autoimmune Diseases - Modern Diseases. In: Policies; DGfI, Policy PDAEaS, editors. Brussels, Belgium2017.
  17. Her M, Kavanaugh A. Alterations in immune function with biologic therapies for autoimmune disease. J Allergy Clin Immunol 2016;137(1):19-27. [https://doi.org/10.1016/j.jaci.2015.10.023] [PMID: 26768759]
  18. Rosenblum MD, Gratz IK, Paw JS, Abbas AK. Treating human autoimmunity: current practice and future prospects. Sci Transl Med 2012;4(125):125sr1-sr1. [https://doi.org/10.1126/scitranslmed.3003504] [PMID: 22422994] [PMCID: PMC4061980]
  19. Biosimilar and interchangable products [webpage]. USA: U.S. Department of Health and Human Services; 2017 [updated 23/10/2017; cited 2018 08/11/2018]. 
  20. Gaw A, Murphy JM, Cowan AR, O'Reilly SJD, Stewart JM, Shepherd J.  Clinical Biochemistry: An Illustrated Colour Text: Churchill Livingstone Elsevier 2008. E-book.
  21. Standardization IOf. ISO 17511. In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials. Geneva, Switzerland 2003. [https://www.iso.org/standard/30716.html]
  22. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic maedical devices, OJ. 1998, No L331  [https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1998L0079:20090807:EN:PDF]
  23. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65(1):1-11. [https://doi.org/10.1002/art.37715] [PMID: 23045170]
  24. Bossuyt X, Cohen Tervaert J-W, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, et al. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017;13:683-92. [https://doi.org/10.1038/nrrheum.2017.140] [PMID: 28905856]
  25. Monogioudi E, Martos G, Hutu DP, Schimmel H, Meroni PL, Sheldon J, et al. Standardization of autoimmune testing - is it feasible? Clin Chem Lab Med 2018;56(10):1734-42. [https://doi.org/10.1515/cclm-2017-1077] [PMID: 29626412]
  26. Meroni PL, Biggioggero M, Pierangeli SS, Sheldon J, Zegers I, Borghi MO. Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases. Nat Rev Rheumatol 2014;10(1):35-43. [https://doi.org/10.1038/nrrheum.2013.180] [PMID: 24275965]
  27. Monogioudi E, Hutu DP, Martos G, Sheldon J, Schimmel H, Meroni PL, et al. Development of a Certified Reference Material for myeloperoxidase-anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA). Clin Chim Acta 2017;467:48-50. [https://doi.org/10.1016/j.cca.2016.05.031] [PMID: 27262820]
  28. Van Blerk M, C. VC, Bossuyt X, Duchateau J, Humbel R, Servais G, et al. Current practices in antinuclear antibody testing: results from the Belgian External Quality Assessment Scheme. Clin Chem Lab Med 2009;47(1):102-8. [https://doi.org/10.1515/CCLM.2009.021] [PMID: 19072028]
  29. UKNEQAS; Participant Feedback Commentary - ANCA Distribution 132  UK: United Kingdom National External Quality Assessment Service for immunology, immunochemistry and allergy, 2013 17/07/2013. Report No.
  30. Miller WG, Schimmel H, Rej R, Greenberg N, Ceriotti F, Burns C, et al. IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design. Clin Chem 2018;64(3):447-54. [https://doi.org/10.1373/clinchem.2017.277525] [PMID: 29348163 ][PMCID: PMC5832613]
  31. Directorate F - Health CaRM. Certified Reference Materials, https://crm.jrc.ec.europa.eu. In: Centre; ECDGJR, editor. Geel, Belgium 2018.
  32. Standardization CA. 2012. Available from: http://asc.dental.ufl.edu.
  33. Monogioudi E, Hutu DP, Martos Sevilla G, Tuddenham E, Sheldon J, Schimmel H, et al. CERTIFICATION REPORT: The certification of anti-myeloperoxidase immunoglobulin G in human serum ERM® - DA476/IFCC. EUR 27092 ed. Belgium: Publications Office of the European Union; 2015.
  34. Monogioudi E, Hutu DP, Charoud-Got J, Sheldon J, Schimmel H, Trapmann S, et al. Certification report: The certification of anti-proteinase 3 immunoglobulin G in human serum ERM® - DA483/IFCC. EUR 28537 EN ed. Belgium: Publications Office of the European Union; 2017.
  35. Goldschmeding R, van der Schoot C, Eten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CG, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989;84(5):1577-87. [https://doi.org/10.1172/JCI114335] [PMID: 2681270] [PMCID: PMC304024]
  36. Falk RJ, Jennette JC. Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic Glomerulonephritis. N Engl J Med 1988;318(25):1651-7. [https://doi.org/10.1056/NEJM198806233182504] [PMID: 2453802]
  37. Standardization IOf. ISO Guide 34: General requirements for the competence of reference material producers. 2009.
  38. Standardization IOf. Reference Materials - General and Statistical principles for certification. ISO Guide 35, 3rd ed. Geneva: International Organisation for Standardisation; 2000.
  39. Blirup-Jensen S, Johnson AM, Larsen M. Protein standardization V: value transfer. A practical protocol for the assignment of serum protein values from a Reference Material to a Target Material. Clin Chem Lab Med 2008;46(10):1470-9. [https://doi.org/10.1515/CCLM.2008.289] [PMID: 18761461]
  40. Zegers I, Schreiber W, Sheldon J, Blirup-Jensen S, Muñoz A, Merlini G, et al. Certification of Proteins in the Human Serum - Certified Reference Material ERM®- DA470k/IFCC. Luxembourg: Office for Official Publications of the European Communities. 2008;Report nr EUR 23431 EN: https://web.jrc.ec.europa.eu/rmcatalogue/detailsrmcatalogue.do?referenceMaterial=DA470k.
  41. Immunology; BSf. Policy Briefing: Autoimmunity. London: Chris Lowry, Public Affairs Manager; 2016.